TMPRSS2 and prostate carcinoma: TMPRSS2:ERG gene fusions have been associated with aggressive prostate cancer in a transgenic mouse model [20], detected in distant metastasis [21] and also linked with aggressive prostate cancer phenotypes in humans [22,23].